PROCEPT BioRobotics Corp cotiza a 19.57 USD y tiene una capitalización bursátil de $1.1B. En los últimos 12 meses ha facturado $337M con un margen de flujo de caja libre del -18.9%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating …
| Periodo | 2026-11 | 2026-08 | 2026-04 | 2026-02 |
|---|---|---|---|---|
| Real | — | $-0.47 | $-0.56 | $-0.53 |
| Estimado | $-0.39 | $-0.45 | $-0.56 | $-0.32 |
| Sorpresa | — | -4.4% | +0.0% | -65.6% |
| Métrica | PRCT | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 63.7% | 57.0% | +6.7% |
| Operating Margin | -33.7% | -38.6% | +4.9% |
| Net Margin | -31.0% | -33.6% | +2.5% |
| FCF Margin | -18.9% | -13.9% | -5.1% |
| ROE | -26.1% | -40.4% | +14.3% |
| ROA | -18.8% | -32.0% | +13.2% |
| Current Ratio | 6.85 | 2.84 | +4.01 |
| Debt / Equity | 0.14 | 0.28 | -0.14 |